Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06890663 · ClinicalTrials.gov registry record · NA
Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health
A NA study, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT06890663: Completed NA study, sponsored by University of Central Florida.
NCT06890663 is a NA study that has completed, run by University of Central Florida. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06890663, a NA study, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.
Primary Outcome
An NIH (National Institutes of Health)-funded initiative to develop and validate patient reported outcomes for clinical research and practice.
Interventions
- OTHER Nonspecific Hypnotherapy for Relaxation
- OTHER Gut-Directed Hypnotherapy (GDH)
- OTHER 3-month Follow-Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
What the finished NCT06890663 record still lists
NCT06890663 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Nonspecific Hypnotherapy for Relaxation is the first listed.
NCT06890663 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06890663 about?
NCT06890663 is a clinical study titled "Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health". This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.
What is the current status of trial NCT06890663?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2025-03-19. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT06890663?
The interventions under investigation include: Nonspecific Hypnotherapy for Relaxation (OTHER), Gut-Directed Hypnotherapy (GDH) (OTHER), 3-month Follow-Up (OTHER).
Who is sponsoring clinical trial NCT06890663?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06890663's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI